JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $31.1 million in its fourth quarter.
On a per-share basis, the Jupiter, Florida-based company said it had a loss of $1.64.
The drugmaker posted revenue of $42.8 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $40 million.
For the year, the company reported a loss of $4 million, or 22 cents per share. Revenue was reported as $167.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
